An expert panel including Kathryn Haskins, PhD, Teresa P. DiLorenzo, PhD, and Megan K. Levins, PhD, will discuss the past, present, and future of T cells in diabetes treatment in a symposium starting at 2:15 p.m. ET.
Up next: T cell research may pave the way for diabetes immunotherapy
